Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Hyperparathyroidism, Primary × Rubidium-82 × Clear all

Status

Not yet recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Tongue Neoplasms 1 Salivary Gland Neoplasms 1 Rectal Neoplasms 1 Parathyroid Neoplasms 1 Oropharyngeal Neoplasms 1 Neovascularization, Pathologic 1 Nasopharyngeal Neoplasms 1 Mouth Neoplasms 1 Lung Neoplasms 1 Laryngeal Neoplasms 1 Hypopharyngeal Neoplasms 1 Hyperparathyroidism, Primary 1 Head and Neck Neoplasms 1 Esophageal Neoplasms 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Renal Cell 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1

Interventions

Cinacalcet 3 Parathyroidectomy 2 fluorocholine 1 evocalcet 1 Tablets 1 Sodium Chloride 1 Rubidium-82 1 Denosumab 1 Congresses as Topic 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07099404 2025-08-22

PARAGON

Montreal Heart Institute

Not yet recruiting

Parathyroid Neoplasms, Hyperparathyroidism, Primary

Data powered by HemOnc (CC BY 4.0) Colophon ⚡